L-carnitine exposure and mitochondrial function in human neuronal cells

Neurochemical Research

Volumn 38, Issue 11, 2013, Pages 2336-2341

  Geier, David A ^a,b   Geier, Mark R ^a,b  

^a Institute of Chronic Illnesses Inc   (United States)

^b Department of Research   (United States)

Author keywords

Carnitine; Cell vitality; Mitochondria; Neuron

Indexed keywords

CARNITINE;

ACUTE DRUG ADMINISTRATION; ARTICLE; ASTROCYTOMA; BRAIN MITOCHONDRION; CELL ASSAY; CELL FUNCTION; CELL GROWTH; CONCENTRATION RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL FUNCTION; NERVE CELL; NERVE CELL CULTURE; NEUROBLASTOMA; PRIORITY JOURNAL;

CARNITINE; COGNITION; HUMANS; MITOCHONDRIA; TUMOR CELLS, CULTURED;

EID: 84886892188     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1144-7     Document Type: Article

References (14)

1. Geier DA, Kern JK, Davis G et al (2011) A prospective double-blind, randomized clinical trial of levocarntine to treat autism spectrum disorders. Med Sci Monit 17(6):PI15-PI23
2. Owen L, Sunram-Lea SI (2011) Metabolic agents that enhance ATP can improve cognitive functioning: a review of the evidence for glucose, oxygen, pyruvate, creatine, and l-carnitine. Nutrients 3(8):735-755
3. Malaguarnera M, Cammalleri L, Gargante MP et al (2007) l-carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr 86(6):1738-1744
4. Battistin L, Pizzolato G, Dam M et al (1989) Single-photon emission computed tomography studies with 99 m Tc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of l-acetylcarnitine. Eur Neurol 29(5):261-265
5. Geier DA, King PG, Geier MR (2009) Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to Thimerosal and other metal compounds. Toxicol Environ Chem 91(4):735-749
6. Nalecz KA, Nalecz MJ (1996) Carnitine-a known compound, a novel function in neural cells. Acta Neurobiol Exp 56(2):597-609
7. Nalecz KA, Miecz D, Berezowski V et al (2004) Carnitine: transport and physiological functions in the brain. Mol Aspects Med 25(5-6):551-567
8. Tulodziecka K, Czeredys M, Nalecz KA (2013) Palmitoylcarnitine affects localization of rowth associated proterin GAP-43 in plasma membrane subdomains and its interaction with Gα(0) in neuroblastoma NB-2a cells. Neurochem Res 38(3):519-529
9. Yu J, Ye J, Han Y et al (2011) Protective effect of l-carnitine against H(2)O(2)-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells. Neurol Res 33(7):708-716
10. Adams JB, Audhya T, McDonough-Means S (2011) Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab 8(1):34
11. Evangeliou A, Vlassopoulos D (2003) Carnitine metabolism and deficit-when supplementation is necessary? Curr Pharm Biotechnol 4(3):211-219
12. Roehm NW, Rodgers GH, Hatfield SM et al (1991) An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142(2):257-265
13. Berridge MV, Herst PM, Tan AS (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 11:127-152
14. Marshall NJ, Goodwin CJ, Holt SJ (1995) A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul 5(2):69-84